Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.
Ruiz Ortiz M, Muñiz J, Raña Míguez P, Roldán I, Marín F, Asunción Esteve-Pastor M, Cequier A, Martínez-Sellés M, Bertomeu V, Anguita M; FANTASIIA study investigators. Ruiz Ortiz M, et al. Among authors: roldan i. Europace. 2018 Oct 1;20(10):1577-1583. doi: 10.1093/europace/eux316. Europace. 2018. PMID: 29186393 Free article.
Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice.
Ruiz Ortiz M, Esteve-Pastor MA, Roldán I, Muñiz J, Marín F, Anguita M; FANTASIIA study investigators. Ruiz Ortiz M, et al. Among authors: roldan i. Rev Esp Cardiol (Engl Ed). 2020 Apr;73(4):329-330. doi: 10.1016/j.rec.2019.09.014. Epub 2019 Nov 27. Rev Esp Cardiol (Engl Ed). 2020. PMID: 31786172 English, Spanish. No abstract available.
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Ortiz MR, Muñiz J, Esteve-Pastor MA, Marín F, Roldán I, Cequier A, Martínez-Sellés M, Saldivar HG, Bertomeu V, Anguita M. Ortiz MR, et al. Among authors: roldan i. J Cardiovasc Pharmacol Ther. 2020 Jul;25(4):316-323. doi: 10.1177/1074248420916316. Epub 2020 Mar 31. J Cardiovasc Pharmacol Ther. 2020. PMID: 32228180
Quality of Anticoagulation With Vitamin K Antagonists.
Bertomeu-González V, Anguita M, Moreno-Arribas J, Cequier Á, Muñiz J, Castillo-Castillo J, Sanchis J, Roldán I, Marin F, Bertomeu-Martínez V; FANTASIIA Study Investigators. Bertomeu-González V, et al. Among authors: roldan i. Clin Cardiol. 2015 Jun;38(6):357-64. doi: 10.1002/clc.22397. Epub 2015 May 11. Clin Cardiol. 2015. PMID: 25962838 Free PMC article.
Oral anticoagulation in octogenarians with atrial fibrillation.
Hugo GS, Figueiras-Graillet LM, Anguita M, Marín F, Bertomeu V, Roldán I, Ruiz M, Muñiz J, Martínez-Sellés M; FANTASIIA registry investigators (see Appendix). Hugo GS, et al. Among authors: roldan i. Int J Cardiol. 2016 Nov 15;223:87-90. doi: 10.1016/j.ijcard.2016.08.004. Epub 2016 Aug 4. Int J Cardiol. 2016. PMID: 27532238 Free article.
[Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischaemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly].
Bonanad Lozano C, Díez-Villanueva P, Blas SG, Ayesta A, Ibars S, Ariza-Solé A, Ferreiro JL, Moreno R, Roldán I, Marín F, Carol Ruiz A, García Pardo H, Sanchís J, Cruz-González I, Anguita M, Cequier Á, Ruiz García J, Martínez-Sellés M. Bonanad Lozano C, et al. Among authors: roldan i. Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):338-342. doi: 10.1016/j.regg.2020.05.008. Epub 2020 Jul 25. Rev Esp Geriatr Gerontol. 2020. PMID: 32718577 Spanish.
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
Moreno-Arribas J, Bertomeu-González V, Anguita-Sanchez M, Cequier Á, Muñiz J, Castillo J, Sanchis J, Roldán I, Marín F, Bertomeu-Martínez V; investigators of the FANTASIIA study. Moreno-Arribas J, et al. Among authors: roldan i. J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):150-6. doi: 10.1177/1074248415596426. Epub 2015 Jul 30. J Cardiovasc Pharmacol Ther. 2016. PMID: 26229096 Free article.
Structural Heart Disease in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Prevalence and Clinical Profile in a Spanish Sample.
Ruiz Ortiz M, Roldán I, Bertomeu V, Muñiz J, Marín F, Anguita M; investigators of the FANTASIIA study. Ruiz Ortiz M, et al. Among authors: roldan i. Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):986-990. doi: 10.1016/j.rec.2016.04.040. Epub 2016 Jul 22. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27461157 English, Spanish. No abstract available.
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
Esteve-Pastor MA, García-Fernández A, Macías M, Sogorb F, Valdés M, Roldán V, Muñiz J, Badimon L, Roldán I, Bertomeu-Martínez V, Cequier Á, Lip GY, Anguita M, Marín F; FANTASIIA Investigators. Esteve-Pastor MA, et al. Among authors: roldan i, roldan v. Circ J. 2016 Sep 23;80(10):2102-8. doi: 10.1253/circj.CJ-16-0471. Epub 2016 Aug 24. Circ J. 2016. PMID: 27557850 Free article.
68 results